Oncotarget

Research Papers:

Curcumin targets the TFEB-lysosome pathway for induction of autophagy

Jianbin Zhang, Jigang Wang, Jian Xu, Yuanqiang Lu, Jiukun Jiang, Liming Wang, Han-Ming Shen _ and Dajing Xia

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:75659-75671. https://doi.org/10.18632/oncotarget.12318

Metrics: PDF 1729 views  |   HTML 1900 views  |   ?  


Abstract

Jianbin Zhang1,2,3,*, Jigang Wang2,*, Jian Xu3, Yuanqiang Lu4, Jiukun Jiang4, Liming Wang2, Han-Ming Shen2,5, Dajing Xia3

1Clinical Research Institute, Zhejiang Provincial People’s Hospital, Hangzhou, China

2Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

3School of Public Health, Zhejiang University, Institute of Immunology, Zhejiang University, Hangzhou, China

4First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

5NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore

*These authors have contributed equally to this work

Correspondence to:

Han-Ming Shen, email: phsshm@nus.edu.sg

Dajing Xia, email: dxia@zju.edu.cn

Keywords: Curcumin, lysosome, mTOR, TFEB, autophagy

Received: July 18, 2016     Accepted: September 16, 2016     Published: September 28, 2016

ABSTRACT

Curcumin is a hydrophobic polyphenol derived from the herb Curcumalonga and its wide spectrum of pharmacological activities has been widely studied. It has been reported that Curcumin can induce autophagy through inhibition of the Akt-mTOR pathway. However, the effect of Curcumin on lysosome remains largely elusive. In this study, we first found that Curcumin treatment enhances autophagic flux in both human colon cancer HCT116 cells and mouse embryonic fibroblasts (MEFs). Moreover, Curcumin treatment promotes lysosomal function, evidenced by the increased lysosomal acidification and enzyme activity. Second, Curcumin is capable of suppressing the mammalian target of rapamycin (mTOR). Interestingly, Curcumin fails to inhibit mTOR and to activate lysosomal function in Tsc2-/-MEFs with constitutive activation of mTOR, indicating that Curcumin-mediated lysosomal activation is achieved via suppression of mTOR. Third, Curcumin treatment activates transcription factor EB (TFEB), a key nuclear transcription factor in control of autophagy and lysosome biogenesis and function, based on the following observations: (i) Curcumin directly binds to TFEB, (ii) Curcumin promotes TFEB nuclear translocation; and (iii) Curcumin increases transcriptional activity of TFEB. Finally, inhibition of autophagy and lysosome leads to more cell death in Curcumin-treated HCT116 cells, suggesting that autophagy and lysosomal activation serves as a cell survival mechanism to protect against Curcumin-mediated cell death. Taken together, data from our study provide a novel insight into the regulatory mechanisms of Curcumin on autophagy and lysosome, which may facilitate the development of Curcumin as a potential cancer therapeutic agent.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12318